376 related articles for article (PubMed ID: 12756151)
21. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
Mazurov AV; Pevzner DV; Antonova OA; Byzova TV; Khaspekova SG; Semenov AV; Vlasik TN; Samko AN; Staroverov II; Ruda MY
Platelets; 2002 Dec; 13(8):465-77. PubMed ID: 12487780
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy of intravenous glycoprotein IIB/IIIA inhibitors and tissue plasminogen activator for acute ischemic stroke.
Dubey D; Banerjee C; Sawhney A; Sharma A; Alberts MJ
Neurol India; 2014; 62(6):631-4. PubMed ID: 25591675
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody [7E3 F(ab')2] prevents arterial but not venous rethrombosis.
Sudo Y; Kilgore KS; Lucchesi BR
J Cardiovasc Pharmacol; 1995 Aug; 26(2):241-50. PubMed ID: 7475049
[TBL] [Abstract][Full Text] [Related]
24. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion.
Zhang ZG; Zhang L; Tsang W; Goussev A; Powers C; Ho KL; Morris D; Smyth SS; Coller BS; Chopp M
Brain Res; 2001 Sep; 912(2):181-94. PubMed ID: 11532435
[TBL] [Abstract][Full Text] [Related]
25. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats.
Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C
Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
Gold HK; Gimple LW; Yasuda T; Leinbach RC; Werner W; Holt R; Jordan R; Berger H; Collen D; Coller BS
J Clin Invest; 1990 Aug; 86(2):651-9. PubMed ID: 2384607
[TBL] [Abstract][Full Text] [Related]
28. Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins.
Liu CZ; Hur BT; Huang TF
Thromb Haemost; 1996 Oct; 76(4):585-91. PubMed ID: 8903000
[TBL] [Abstract][Full Text] [Related]
29. FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban.
Moriguchi A; Maeda M; Mihara K; Aoki T; Matsuoka N; Mutoh S
J Cereb Blood Flow Metab; 2005 Jan; 25(1):75-86. PubMed ID: 15678114
[TBL] [Abstract][Full Text] [Related]
30. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.
Zhang L; Zhang Z; Zhang RL; Cui Y; LaPointe MC; Silver B; Chopp M
Brain Res; 2006 Nov; 1118(1):192-8. PubMed ID: 16959227
[TBL] [Abstract][Full Text] [Related]
31. Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogs.
Kiss RG; Lu HR; Roskams T; Jang IK; Plow EF; Gold HK; Collen D
Arterioscler Thromb; 1994 Mar; 14(3):367-74. PubMed ID: 8123640
[TBL] [Abstract][Full Text] [Related]
32. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
Jin R; Xiao AY; Liu S; Wang M; Li G
Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
[TBL] [Abstract][Full Text] [Related]
33. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
Lapchak PA; Zivin JA
Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats.
Zhang L; Chopp M; Jia L; Cui Y; Lu M; Zhang ZG
J Cereb Blood Flow Metab; 2009 Nov; 29(11):1816-24. PubMed ID: 19638998
[TBL] [Abstract][Full Text] [Related]
35. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
[TBL] [Abstract][Full Text] [Related]
36. Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats.
Shehadah A; Chen J; Cui Y; Zhang L; Roberts C; Lu M; Chopp M
J Neurol Sci; 2011 Oct; 309(1-2):96-101. PubMed ID: 21802695
[TBL] [Abstract][Full Text] [Related]
37. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
38. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
Lapchak PA
Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
[TBL] [Abstract][Full Text] [Related]
40. PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.
Jin R; Xiao AY; Li J; Wang M; Li G
Hypertension; 2019 Jan; 73(1):206-216. PubMed ID: 30571560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
